Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancer.
about
The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90.Serum HER2 level measured by dot blot: a valid and inexpensive assay for monitoring breast cancer progression.Circulating tumor cells in breast cancer.Single-domain antibodies: a versatile and rich source of binders for breast cancer diagnostic approaches.Clinical outcome of adjuvant endocrine treatment according to Her-2/neu status in breast cancer.HER-2/neu diagnostics in breast cancer.Docetaxel/trastuzumab combination therapy for the treatment of breast cancer.Circulating oncoproteins HER2/neu, EGFR and CAIX (MN) as novel cancer biomarkers.Predicting brain metastases of breast cancer based on serum S100B and serum HER2.Cancer biomarker HER-2/neu in breast cancer in Indian womenUsefulness of traditional serum biomarkers for management of breast cancer patients.Engineered multifunctional nanocarriers for cancer diagnosis and therapeutics.Update on HER2 testing for breast and upper gastrointestinal tract cancers.Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancer.HER2-positive gastric cancer identified by serum HER2: A case report.Serum HER-2: sensitivity, specificity, and predictive values for detecting metastatic recurrence in breast cancer patients.Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologics.Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer.
P2860
Q33676854-9C74ECF7-AA19-4344-AB6F-95F7B31D9EEAQ33886818-FF49B224-73AC-416C-A1B9-75CB38524AA0Q34077349-88CF039A-0CF2-4DB5-9A8E-314FFA8AA90FQ34330122-91B526BA-B001-4AF8-98AC-9F3FA92BF9F6Q34999423-EC992394-0794-472F-BCDC-3E568B68F5F2Q35906255-B072A7E8-C234-4E32-A6BF-04A254334944Q36222001-22DCF491-22FB-47B3-8BE5-248F6577A90AQ36816042-09E85414-7896-4ACE-A5C0-BB057E7B124FQ37269532-6A327330-BC46-4ECF-AF48-57315EE0E9BDQ37356034-6773C877-8D96-4DEB-B4BE-571874489C79Q37375636-AD153B56-0012-4133-9A2A-A47C68EADCDAQ37885883-DE846AFB-592E-4F2C-B8DE-646B13B2232AQ37886993-24F24F0E-BF94-4417-8A4C-1C06BD956C53Q38859024-6DC58C6E-5D04-41BC-9AFA-4710781453EDQ41821055-8BB2FCAD-BDBB-4A2C-9B63-13BEFE8F5387Q44056799-EEB37554-3158-4F25-8E78-5D021F49F1BAQ47243379-AFD92A19-AF11-49E7-95CF-C7267D2CE5AFQ49787807-A47E2505-4E19-4AE5-B69D-F3BCC1633A85
P2860
Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancer.
@ast
Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancer.
@en
type
label
Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancer.
@ast
Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancer.
@en
prefLabel
Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancer.
@ast
Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancer.
@en
P2093
P356
P1476
Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancer.
@en
P2093
Allan Lipton
Christopher P Price
Kim Leitzel
Rainer Neumann
Suhail Ali
Walter P Carney
P304
P356
10.3816/CBC.2004.N.014
P407
P577
2004-06-01T00:00:00Z